Curanex PharmaceuticalsCURX
13F holders, Q1 2026 (March 31)8holders −3
2new positions
5sold out
1famous investor
$0.51avg. 13F price*
At the end of Q1 2026, 8 institutions reported holding Curanex Pharmaceuticals Inc. (CURX) in their 13F filings, down 3 from Q4 2025. 2 opened new positions and 5 sold out. The largest holders were Geode Capital Management, LLC ($57K), Two Sigma Securities, LLC ($29K) and XTX Topco Ltd ($26K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Curanex Pharmaceuticals Inc.
- CUSIP
- 23126K106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $39K |
| Exits | 5 | $56K |
All 13F filers, Q4 2025 → Q1 2026: 177,347 shares bought and 274,715 shares sold, net −97,368 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Geode Capital Management, LLC | 0.00% | Add +495.2% | 111,130 | $57K |
| Two Sigma Securities, LLC | 0.00% | New | 56,651 | $29K |
| XTX Topco Ltd | 0.00% | Add +21.0% | 51,289 | $26K |
| Citadel Advisors | 0.00% | Reduce -51.5% | 50,559 | $26K |
| Two Sigma Investments, LP | 0.00% | Reduce -66.8% | 20,254 | $10K |
| Citigroup Inc. | 0.00% | New | 19,332 | $10K |
| Jump Financial, LLC | 0.00% | Reduce -39.5% | 10,551 | $5K |
| UBS Group AG | 0.00% | Reduce -38.5% | 7,995 | $4K |
"% of holder's portfolio" is CURX's weight in each manager's 13F, not the share of Curanex Pharmaceuticals Inc. the manager owns.